Fundz

Sonic Healthcare Acquires Strategic Stake In Microba Life Sciences, Establishes Significant Commercial Partnership

PRIVATENov 29, 2022

Acquiring Company

Microba Life Sciences Limited

Acquired Company

Microba Life Sciences Limited

BiotechnologyHealth CareMedicalTherapeuticsBiotechnologyHealth CareMedicalTherapeutics

Description

Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is pleased to announce that leading medical diagnostics provider Sonic Healthcare Limited (ASX: SHL) (“Sonic”) has agreed to invest $17.8m to acquire a 19.99% shareholding in Microba. In addition, Sonic is seeking to acquire options for an additional 5% equity position, subject to shareholder approval. Exercise of the options by Sonic would result in a further investment of $7.5m in Microba.

Who to call at Microba Life Sciences Limited, and when

When Microba Life Sciences Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Microba Life Sciences Limited raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Microba Life Sciences Limited, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Microba Life Sciences Limited

About

Microba Life Sciences is a precision microbiome company driven to improve human health. With world-leading technology for measuring the human gut microbiome, Microba is driving the discovery and development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. Through partnerships with leading organisations, Microba is powering the discovery of new relationships between the microbiome, health and disease for the development of new health solutions. www.microba.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Microba Life Sciences Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Alaster
Senior decision-maker at this company
••••••••@••••••••

See Alaster's verified email →

Jenni
Senior decision-maker at this company
••••••••@••••••••

See Jenni's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Microba Life Sciences Limited's next move

Learn about Strategic plan

Frequently asked

Who acquired Microba Life Sciences Limited?

Microba Life Sciences Limited was acquired by Microba Life Sciences Limited. The deal was reported on November 29, 2022. Microba Life Sciences is a precision microbiome company driven to improve human health. Microba Life Sciences Limited is privately held and operates in Biotechnology.

When did Microba Life Sciences Limited acquire Microba Life Sciences Limited?

Microba Life Sciences Limited's acquisition of Microba Life Sciences Limited was reported on November 29, 2022. Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is pleased to announce that leading medical diagnostics provider Sonic Healthcare Limited (ASX: SHL) (“Sonic”) has agreed to invest $17.8m to acquire a 19.99% shareholding in Microba. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Microba Life Sciences Limited do?

Microba Life Sciences is a precision microbiome company driven to improve human health. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.